PubMed COVID-19 Clinical Care

Introduction: Coronavirus disease 2019 (COVID-19) can lead to acute respiratory distress syndrome (ARDS) and life-threatening multi-organ failure with increased levels of inflammatory mediators and viral load; however, little is known about its

Under the influence of the global COVID-19 pandemic, the demand for medical equipment and epidemic prevention materials has increased significantly, but the existing production lines are not flexible and efficient enough to dynamically adapt to

Coronaviruses cause respiratory and intestinal infections in animals and humans. By the end of 2019, there was an epidemic of novel coronavirus (COVID-19), which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

The healthcare system in Austria is currently affected by supply chain problems for certain drugs. These are mainly low-priced drugs, but they are of great importance for our health system. A sudden, excessive demand cannot be compensated by the drug

CONCLUSION AND RECOMMENDATIONS: HCWs were reluctant to get the SARS-CoV-2 immunization at a high percentage overall. To reduce hesitancy to receive the SARS-CoV-2 vaccination among HCWs, the Oromia regional state health bureau should be required to

CONCLUSION: COVID-19 infections can cause severe damage to blood vessels, especially in the context of other etiologies that can further damage the vasculature. This report demonstrates the importance of patient follow-up and monitoring post-COVID-19

CONCLUSION: Prompt diagnosis and evaluation of DKA in pregnancy as well as a higher level of suspicion is needed in the setting of SARS-CoV-2 infection. Additionally, this case depicts the need for closely monitoring the postpartum period for

CONCLUSION: MSCs and their extracellular vesicles can significantly reduce the serum levels of inflammatory markers in COVID-19 patients, with no serious adverse events. Trial registration IRCT, IRCT registration number: IRCT20200217046526N2

CONCLUSIONS: Multidisciplinary rehabilitation may result in improved functional outcomes on discharge from rehabilitation units/centres for older adults with COVID-19. Findings also highlight the need for further research into the long-term effect of

Lipid nanoparticle (LNP)-formulated messenger RNA (mRNA) vaccineare a promising platform to prevent infectious diseases as demonstrated by the recent success of SARS-CoV-2 mRNA vaccines. To avoid immune recognition and uncontrolled inflammation